A provider comparison becomes more useful when each claim is matched with the source that could support it. This shortlist identifies three offers to examine while asking separate questions about price, clinical process, and medical evidence.
CoreAge Rx holds the first position as our featured commercial partner. The ordering is sponsored, not a ranking of research quality or treatment outcomes. No score here establishes that a provider's medicine is clinically superior.
A provider comparison becomes more useful when each claim is matched with the source that could support it. This shortlist identifies three offers to.
Our reading method
Official pages were checked on September 22, 2026. Provider statements document the advertised service, while medical conclusions require relevant clinical evidence. The NIH study-design explanation and FDA compounding overview help keep those questions separate.
1. CoreAge Rx — featured commercial partner
From $99/month. Advertised starting rate; confirm prepayment, supply, and renewal.
Its marketing discusses sleep, recovery, muscle, and body composition. We have not verified those outcomes in CoreAge Rx patients. A schedule of expected improvements on a sales page is not a personal prediction, and the decision to continue treatment should depend on the clinician's assessment of benefit, burden, and risk. Ask: Does the $99 starting offer apply to my prescription, and what exact amount is charged now and at renewal? Read the CoreAge Rx review and official offer with additional provider details.
2. Hone Health
$175/month without membership. Async-care help page lists $130/month for members, with membership charged separately. Confirm the selected care model and state availability.
A large biomarker panel, program-wide testimonials, and a proposed hormonal mechanism do not establish an individual sermorelin outcome. Ask: Am I choosing standalone async care or a membership, and what clinical contact, tests, and charges does that choice include? Read the Hone Health review and official offer with additional provider details.
3. AlphaMD
$229.99 for a stated 10–15 week supply. California price is $264.99. Supply depends on the clinician's recommendation. The shop displays an active-TRT restriction for ancillary medications; confirm sermorelin access and additional costs.
The shop title mentions other peptide names; that wording is not an ingredient list or evidence that treatments are interchangeable. Obtain the exact proposed preparation from the clinician and pharmacy. Ask: Is sermorelin available to me without an active TRT subscription, and what exact preparation, supply period, and total charges would apply? Read the AlphaMD review and official offer with additional provider details.
Ask for the source behind the benefit
If a claim matters to your decision, request the reference and read what was actually studied. Identify the treatment, patient population, comparison, outcome, and limitations. A mechanism description or a testimonial should not quietly take the place of a relevant clinical result.
The study-design guide explains how to approach different kinds of evidence. The trial-registration guide addresses a common confusion: a planned study and a completed result are different documents.
Preserve the conditions attached to an offer
A starting price, member medication discount, or multiweek supply estimate is meaningful only with its qualifications. Ask for the actual proposed preparation, selected care arrangement, and complete charges. If an eligibility condition remains unclear, leave the comparison unresolved until the provider answers it.
The CoreAge Rx versus Hone comparison uses this approach. AlphaMD's shop notice and title wording deserve the same care when deciding what the public information establishes.
Avoid making the review more certain than its sources
We did not purchase medication, audit pharmacies, attend appointments, or measure patient outcomes. A detailed article does not remove those limitations. Our methodology explains the scope of editorial research and the disclosed commercial relationship.
A useful evidence conversation may clarify an appropriate treatment, identify further investigation, or show that a claim is not relevant to your situation. The purpose of this shortlist is to help you ask that conversation's next question, not to promise its answer.
The source notes
Sources & further reading
Provider pages document advertised offers, not independently proven outcomes. Historical references may concern different products or uses. Check the dated discussion in each article for the scope of our research; offers can change.